Senior insider sale
Chief Scientific Officer at CONTINEUM THERAPEUTICS, INC. — senior position signals high conviction
$919.6K
57.39K shares
LORRAIN DANIEL S. plans to sell 57.39K shares of CONTINEUM THERAPEUTICS, INC. valued at approximately $919.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Exercise of Stock Options
Cash
Restricted Stock Units
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2026 | Exercise of Stock Options Cash | 5.35K | — |
5/9/2017 | Restricted Stock Units N/A | 4.17K | — |
| Total | 9.52K | ||
Completed
Units to sell
9.52K
Market value
$151.8K
Units to sell
127.00
Market value
$2.0K
Units to sell
25.00
Market value
$400.00
Units to sell
1.01K
Market value
$16.2K
Units to sell
8.35K
Market value
$132.3K
Units to sell
28.83K
Market value
$462.3K
Planned — Approximate Date
Units to sell
9.52K
Market value
$154.6K
Units
57.39K
Value
$919.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/3/2026 | 9.52K | $151.8K | — | Completed |
7/31/2026 | 127.00 | $2.0K | — | Completed |
7/9/2026 | 25.00 | $400.00 | — | Completed |
7/8/2026 | 1.01K | $16.2K | — | Completed |
7/1/2026 | 8.35K | $132.3K | — | Completed |
6/30/2026 | 28.83K | $462.3K | — | Completed |
| Planned — Approximate Date | ||||
9/1/2026 | 9.52K | $154.6K | NASDAQ | Planned |
| Total | 57.39K | $919.6K | ||